Powder: -20°C for 3 years | In solvent: -80°C for 2 years
VU0410150, a pyrrylarylsulfone containing compound, has been found to be a mGluR4-positive allosteric modulator and has been evaluated as a potential drug for the treatment of Parkinson’s disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 6-8 weeks | $ 970.00
$ 776.00
|
|
50 mg | 6-8 weeks | $ 1,980.00
$ 1,584.00
|
|
100 mg | 6-8 weeks | $ 2,500.00
$ 2,000.00
|
Description | VU0410150, a pyrrylarylsulfone containing compound, has been found to be a mGluR4-positive allosteric modulator and has been evaluated as a potential drug for the treatment of Parkinson’s disease. |
Synonyms | VU 0410150, VU-0410150 |
Molecular Weight | 355.41 |
Formula | C18H17N3O3S |
CAS No. | 1296731-74-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VU0410150 1296731-74-2 VU 0410150 VU-0410150 inhibitor inhibit